Percutaneous microwave ablation on management of hereditary renal cell carcinoma in Von Hippel–Lindau disease

References

• Maher ER, Yates JR, Harries R, et al. Clinical features and natural history of von Hippel-Lindau disease. Q J Med. 1990;77(283):1151–1163. doi: 10.1093/qjmed/77.2.1151.
   PubMedGoogle Scholar
• Lonser RR, Glenn GM, Walther M, et al. Von Hippel-Lindau disease. Lancet. 2003;361(9374):2059–2067. doi: 10.1016/S0140-6736(03)13643-4.
   PubMed Web of Science ®Google Scholar
• Nielsen SM, Rhodes L, Blanco I, et al. Von Hippel-Lindau disease: genetics and role of genetic counseling in a multiple neoplasia syndrome [published correction appears in J clin oncol. 2016 oct 10;34(29):3588]. J Clin Oncol. 2016;34(18):2172–2181. doi: 10.1200/JCO.2015.65.6140.
   PubMed Web of Science ®Google Scholar
• Neumann HP, Bender BU, Berger DP, et al. Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinoma. J Urol. 1998;160(4):1248–1254. doi: 10.1016/S0022-5347(01)62509-6.
   PubMed Web of Science ®Google Scholar
• Duffey BG, Choyke PL, Glenn G, et al. The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease. J Urol. 2004;172(1):63–65. doi: 10.1097/01.ju.0000132127.79974.3f.
   PubMed Web of Science ®Google Scholar
• Verine J, Pluvinage A, Bousquet G, et al. Hereditary renal cancer syndromes: an update of a systematic review. Eur Urol. 2010;58(5):701–710. doi: 10.1016/j.eururo.2010.08.031.
   PubMed Web of Science ®Google Scholar
• Park BK, Kim CK. Percutaneous radio frequency ablation of renal tumors in patients with von Hippel-Lindau disease: preliminary results. J Urol. 2010;183(5):1703–1707. doi: 10.1016/j.juro.2010.01.022.
   PubMed Web of Science ®Google Scholar
• Park SY, Park BK, Kim CK, et al. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von hippel lindau disease previously undergoing a radical nephrectomy or repeated nephron-sparing surgery. Acta Radiol. 2011;52(6):680–685. doi: 10.1258/ar.2011.100435.
   PubMed Web of Science ®Google Scholar
• Iwamoto Y, Kanda H, Yamakado K, et al. Management of renal tumors in von Hippel-Lindau disease by percutaneous CT fluoroscopic guided radiofrequency ablation: preliminary results. Fam Cancer. 2011;10(3):529–534. doi: 10.1007/s10689-011-9440-3.
   PubMed Web of Science ®Google Scholar
• Wah TM, Lenton J, Smith J, et al. Irreversible electroporation (IRE) in renal cell carcinoma (RCC): a mid-term clinical experience. Eur Radiol. 2021;31(10):7491–7499. doi: 10.1007/s00330-021-07846-5.
   PubMed Web of Science ®Google Scholar
• Yu J, Zhang X, Liu H, et al. Percutaneous microwave ablation versus laparoscopic partial nephrectomy for cT1a renal cell carcinoma: a propensity-matched cohort study of 1955 patients. Radiology. 2020;294(3):698–706. doi: 10.1148/radiol.2020190919.
   PubMed Web of Science ®Google Scholar
• Klapperich ME, Abel EJ, Ziemlewicz TJ, et al. Effect of tumor complexity and technique on efficacy and complications after percutaneous microwave ablation of stage T1a renal cell carcinoma: a single-Center, retrospective study. Radiology. 2017;284(1):272–280. doi: 10.1148/radiol.2016160592.
   PubMed Web of Science ®Google Scholar
• Charlson M, Szatrowski TP, Peterson J, et al. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245–1251. doi: 10.1016/0895-4356(94)90129-5.
   PubMed Web of Science ®Google Scholar
• Kutikov A, Uzzo RG. The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol. 2009;182(3):844–853. doi: 10.1016/j.juro.2009.05.035.
   PubMed Web of Science ®Google Scholar
• Yu J, Yu XL, Cheng ZG, et al. Percutaneous microwave ablation of renal cell carcinoma: practice guidelines of the ultrasound committee of chinese medical association, interventional oncology committee of chinese research hospital association. Int J Hyperthermia. 2020;37(1):827–835. doi: 10.1080/02656736.2020.1779356.
   PubMed Web of Science ®Google Scholar
• Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–213. doi: 10.1097/01.sla.0000133083.54934.ae.
   PubMed Web of Science ®Google Scholar
• Steinbach F, Novick AC, Zincke H, et al. Treatment of renal cell carcinoma in von Hippel-Lindau disease: a multicenter study. J Urol. 1995;153(6):1812–1816. doi: 10.1016/S0022-5347(01)67318-X.
   PubMed Web of Science ®Google Scholar
• Ploussard G, Droupy S, Ferlicot S, et al. Local recurrence after nephron-sparing surgery in von Hippel-Lindau disease. Urology. 2007;70(3):435–439. doi: 10.1016/j.urology.2007.04.040.
   PubMed Web of Science ®Google Scholar
• Reed AB, Parekh DJ. Surgical management of von Hippel-Lindau disease: urologic considerations. Surg Oncol Clin N Am. 2009;18(1):157–174, x. doi: 10.1016/j.soc.2008.08.005.
   PubMed Web of Science ®Google Scholar
• Chan VW, Lenton J, Smith J, et al. Multimodal image-guided ablation on management of renal cancer in Von-Hippel-lindau syndrome patients from 2004 to 2021 at a specialist Centre: a longitudinal observational study. Eur J Surg Oncol. 2022;48(3):672–679. doi: 10.1016/j.ejso.2021.10.022.
   PubMed Web of Science ®Google Scholar
• Hines-Peralta A, Goldberg SN. Review of radiofrequency ablation for renal cell carcinoma. Clin Cancer Res. 2004;10(18 Pt 2):6328S–6334S. doi: 10.1158/1078-0432.CCR-050004.
   PubMed Web of Science ®Google Scholar
• Morkos J, Porosnicu Rodriguez KA, Zhou A, et al. Percutaneous cryoablation for stage 1 renal cell carcinoma: outcomes from a 10-year prospective study and comparison with matched cohorts from the national cancer database. Radiology. 2020;296(2):452–459. doi: 10.1148/radiol.2020192325.
   PubMed Web of Science ®Google Scholar
• Yu J, Liang P. Status and advancement of microwave ablation in China. Int J Hyperthermia. 2017;33(3):278–287. doi: 10.1080/02656736.2016.1243261.
   PubMed Web of Science ®Google Scholar
• Johnson A, Sudarshan S, Liu J, et al. Feasibility and outcomes of repeat partial nephrectomy. J Urol. 2008;180(1):89–93; discussion 93. doi: 10.1016/j.juro.2008.03.030.
   PubMed Web of Science ®Google Scholar
• Park BK, Kim CK, Park SY, et al. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von hippel lindau disease: indications, techniques, complications, and outcomes. Acta Radiol. 2013;54(4):418–427. doi: 10.1177/0284185113475441.
   PubMed Web of Science ®Google Scholar
• Park SY, Park BK, Kim CK. Thermal ablation in renal cell carcinoma: what affects renal function? Int J Hyperthermia. 2012;28(8):729–734. doi: 10.3109/02656736.2012.728017.
   PubMed Web of Science ®Google Scholar
• Volpe A, Blute ML, Ficarra V, et al. Renal ischemia and function after partial nephrectomy: a collaborative review of the literature. Eur Urol. 2015;68(1):61–74. doi: 10.1016/j.eururo.2015.01.025.
   PubMed Web of Science ®Google Scholar